Atlas Trials

HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025

Clinical trial NCT02095210 · TERMINATED

Trial details

NCT number
NCT02095210
Sponsor
Dorte Nielsen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
HER2-positive Breast Cancer
Start date
2011-08-01
Primary completion
2014-08-13
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.